Company intelligence / Profile preview

Hyalogic

Riverside, Missouri, United States

Ownership: Private
Employees: ~25
Development stage: Other

Overview

Hyalogic is a leading developer of premium hyaluronic acid (HA) products for both human and animal health. Founded in 2002 and headquartered in Riverside, Missouri, the company specializes in high molecular weight HA supplements and topical applications designed to support joint health, skin hydration, and overall wellness. Their product portfolio includes oral supplements, skincare serums, and specialized formulas for pets and equine athletes. Hyalogic is recognized for pioneering the use of liquid HA in the retail market and maintains a focus on science-based, fermentation-derived formulations.

Therapeutic areas: OphthalmologyRheumatologyDermatology
Modalities: BiologicSmall molecule
Industry: Non-Drug Biotech

Beyond the preview

Go deeper on Hyalogic.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hyalogic.

Explore the full profile